In a major setback to fighting tuberculosis (TB), the first clinical trial of a shortened treatment has been forced to shut down the enrollment of new participants. The trial aimed to evaluate the safety and effectiveness of a three-month course of drugs, but interim analysis revealed high rates of unfavorable outcomes. Globally, tuberculosis is the second…

Over the past few years, we have experienced isolation, mask-wearing, and significant behavioral changes in response to a declared pandemic. As that emergency fades into the “new normal” of our post-COVID world—the mass migration of people into Western countries is setting the stage for something potentially worse. The escalating influx of individuals from various regions…

Commentary So many people made bank (both power and money) on the last pandemic, they are already preparing for a new one. The bit about Monkeypox (remember that health emergency only a year ago?) didn’t really go well, so they are reverting again to the fear of infectious disease, this time the old standby H5N1,…

Sprinkled like confetti throughout this image are dozens of green, yellow, and red-ringed axons—nerve cell fibers that transmit electrical signals throughout the nervous system. The axons are bundled in a human cranial nerve, shown here in a cross-section view (see illustration below for context). Nerves like this exit the brainstem and project to areas of…

One of the world’s leading killer infectious diseases—tuberculosis (TB)— is surging in the United States with cases rising more than 9 percent last year alone. At present, an estimated 13 million people are living in the United States with latent TB infections, according to the Centers for Disease Control and Prevention (CDC). TB kills upwards…